Walther Therapeutics ApS
CVR 45762505 · Private limited company (ApS) · Active · High risk
Walther Therapeutics ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.8% over the next 12 months, which is 2.0 times the average for Danish companies. CEO: Sebastian Honoré.
Bankruptcy risk for Walther Therapeutics ApS
2.0 × the average (1.41%) · higher risk than 87% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45762505
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- Ole Maaløes Vej 3
2200 København N - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 100k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 0 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 167 |
| Going-concern uncertainty | No |
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Sebastian Honoré | Current | |
| Owner (100%) | Cure Lowe Foundation | Current | |
| Founder | Cure Lowe Foundation | Current |
Address history (0 moves)
| Ole Maaløes Vej 3, 2200 København N |
Other companies at the same address
- 25-06-2019 ApS Bankrupt
- Ankrin Therapeutics ApS Bankrupt
- Avineuro ApS Bankrupt
- BIOREPELLER IVS Bankrupt
- Bainan Biotech ApS Bankrupt
- Broselid Holding IVS Bankrupt
- ChildTreat ApS Bankrupt
- Dencomm ApS Bankrupt
- IO BIOTECH ApS Bankrupt
- Invitreo Biosciences ApS Bankrupt
- Lab Hos Development ApS Bankrupt
- MGM BIO IVS Bankrupt
- Mind the Byte ApS Bankrupt
- PanCryos ApS Bankrupt
- Ressaissi Holding IVS Bankrupt
- SSIP 2023 ApS Bankrupt
- Spit Test Company ApS Bankrupt
- Sterisafe Holding A/S Bankrupt
- Sumondo ApS Bankrupt
- TychoBio IVS Bankrupt
- aiwell Nordic ApS Bankrupt
- 1stBiome ApS Active
- 3Sonic ApS Active
- 55 North General Partner I ApS Active
- 55 North Management ApS Active
Similar companies in København
- AffiCon ApS Valby
- EXTITUTION ApS København Ø
- Coco Sense ApS København NV
- Everllence Denmark A/S København SV
- BioSpectre ApS København V
- Nordic Cell Therapy Group ApS København N
- FiberSure ApS København Ø
- Tasira ApS København N
- Xenogen ApS København S
- Magnalev Core ApS København SV
- Pin Joint ApS København S
- Maglya ApS København Ø
Questions and answers about Walther Therapeutics ApS
Has Walther Therapeutics ApS gone bankrupt?
No, Walther Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Walther Therapeutics ApS?
Our model estimates a bankruptcy risk of 2.8% over the next 12 months (high risk), which is 2.0 times the average for Danish companies.
Who is the CEO of Walther Therapeutics ApS?
Sebastian Honoré is the CEO of Walther Therapeutics ApS.
When was Walther Therapeutics ApS founded?
Walther Therapeutics ApS was founded on 21 July 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.